AU6746387A - New derivatives - Google Patents

New derivatives

Info

Publication number
AU6746387A
AU6746387A AU67463/87A AU6746387A AU6746387A AU 6746387 A AU6746387 A AU 6746387A AU 67463/87 A AU67463/87 A AU 67463/87A AU 6746387 A AU6746387 A AU 6746387A AU 6746387 A AU6746387 A AU 6746387A
Authority
AU
Australia
Prior art keywords
new derivatives
derivatives
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67463/87A
Inventor
Klaus Grohe
Hermann Hagemann
Karl Georg Metzger
Uwe Petersen
Thomas Schenke
Hans-Joachim Zeiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU6746387A publication Critical patent/AU6746387A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
AU67463/87A 1986-01-21 1987-01-09 New derivatives Abandoned AU6746387A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3601567 1986-01-21
DE19863601567 DE3601567A1 (en) 1986-01-21 1986-01-21 7- (AZABICYCLOALKYL) -CHINOLONCARBONIC ACID AND -NAPHTHYRIDON-CARBONIC ACID DERIVATIVES

Publications (1)

Publication Number Publication Date
AU6746387A true AU6746387A (en) 1987-07-23

Family

ID=6292237

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67463/87A Abandoned AU6746387A (en) 1986-01-21 1987-01-09 New derivatives

Country Status (16)

Country Link
EP (1) EP0230274A3 (en)
JP (1) JPS62169789A (en)
KR (1) KR870007176A (en)
CN (1) CN87100354A (en)
AU (1) AU6746387A (en)
DD (1) DD265401A5 (en)
DE (1) DE3601567A1 (en)
DK (1) DK29287A (en)
FI (1) FI870200A (en)
HU (1) HUT45531A (en)
IL (1) IL81291A0 (en)
NO (1) NO870126L (en)
PL (1) PL263735A1 (en)
PT (1) PT84135A (en)
SU (1) SU1538897A3 (en)
ZA (1) ZA87380B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611400B2 (en) * 1986-10-08 1991-06-13 Bristol-Myers Squibb Company 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
US5849752A (en) * 1995-12-12 1998-12-15 Bayer Aktiengesellschaft Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI88506C (en) * 1986-07-04 1993-05-25 Chemie Linz Gmbh For example, 7-diazabicycloalkyl-6-fluoro-1- (2,4-difluorophenyl) -1,4-dihydro-4-oxo-quinoline-3-carboxylic acid or carboxylic acid ester can be obtained from the pharmaceutical industry.
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4968799A (en) * 1987-07-31 1990-11-06 Warner-Lambert Company Antibacterial agents
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4992546A (en) * 1987-07-31 1991-02-12 Warner-Lambert Company Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
JPH0228178A (en) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd Novel pyridonecarboxylic acid derivative and salt thereof
KR910003630B1 (en) * 1988-06-17 1991-06-07 한국과학기술원 Benzoyl acetic ester derivatives and there of method
DE3910663A1 (en) * 1989-04-03 1990-10-04 Bayer Ag 5-ALKYLCHINOLON CARBONIC ACIDS
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
FR2656611B1 (en) * 1990-01-04 1992-05-07 Hoechst France NEW QUINOLONES, THEIR SALTS, USEFUL AS ANTIMICROBIAL AGENTS, PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM.
US6184380B1 (en) 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
SE0003795D0 (en) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3281423A (en) * 1964-02-03 1966-10-25 Merck & Co Inc 1, 3-ethanopiperazines and process
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
CA1285279C (en) * 1984-02-17 1991-06-25 Joseph P. Sanchez 7-amine derivatives of 1-cyclopropyl-6,8-difluoro-1,4- dihydro-4-oxo-3-quinolinecarboxylic acids and 1-cyclopropyl-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine- 3-carboxylic acidsas antibacterial agents
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
IN166416B (en) * 1985-09-18 1990-05-05 Pfizer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611400B2 (en) * 1986-10-08 1991-06-13 Bristol-Myers Squibb Company 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
US5849752A (en) * 1995-12-12 1998-12-15 Bayer Aktiengesellschaft Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification

Also Published As

Publication number Publication date
DK29287A (en) 1987-07-22
DE3601567A1 (en) 1987-07-23
EP0230274A3 (en) 1988-03-09
JPS62169789A (en) 1987-07-25
IL81291A0 (en) 1987-08-31
PL263735A1 (en) 1988-07-21
DK29287D0 (en) 1987-01-20
ZA87380B (en) 1987-09-30
NO870126L (en) 1987-07-22
SU1538897A3 (en) 1990-01-23
HUT45531A (en) 1988-07-28
KR870007176A (en) 1987-08-17
FI870200A (en) 1987-07-22
EP0230274A2 (en) 1987-07-29
FI870200A0 (en) 1987-01-19
PT84135A (en) 1987-02-01
DD265401A5 (en) 1989-03-01
CN87100354A (en) 1987-09-02
NO870126D0 (en) 1987-01-13

Similar Documents

Publication Publication Date Title
AU591564B2 (en) 5-acylamino-pyrazole derivatives
AU7299387A (en) Imidazoquinolinylether derivatives
AU602913B2 (en) Substituted benzoylphenylureas
AU591007B2 (en) 3-aryloxy-3-substituted propanamines
AU2753588A (en) New derivatives
AU8225487A (en) Pyridazodiazepine derivatives
AU593093B2 (en) Radio-direction-finding
AU575745B2 (en) Alkylsulfonanilide derivatives
AU6899587A (en) Substituted indoloquinoxalines
AU6746387A (en) New derivatives
AU589685B2 (en) New derivatives
AU7596987A (en) Novel 18-phenyloestrane derivatives
AU7109387A (en) Substituted aminoxy-propanoates
AU590687B2 (en) 5-acylamino-pyrazole derivatives
AU5988990A (en) 3-alkoxy-2-aminopropylamides
AU573115B2 (en) 2b-substituted thiomethylpenicillin derivatives
AU7791787A (en) Sulphonamidoethyl derivatives
AU626472B2 (en) 1-n-dodecylazacycloheptane-2-thione
AU579047B2 (en) Pyridopyrimidinediones
AU7045587A (en) 5-amino-1-aryl-pyrazole derivatives
AU6989587A (en) Arylazolylmethylbenzocycloalkene derivatives
AU6886087A (en) 2-cyanobenimidazole derivatives
AU7109287A (en) Substituted aminoxy-propionamides
AU581809B2 (en) Indenopyrimidine derivatives
AU7389687A (en) Aralkylimidazole derivatives